LFB Plasma

LFB Plasma is the U.S. plasma collection subsidiary of LFB Group, focused on sourcing high-quality human plasma from compensated donors through a network of collection centers. The company does not primarily develop its own clinical drug pipeline; instead, it supports the manufacture of plasma-derived therapies and medicines used in serious and often rare diseases. Its role in the value chain is upstream and operational, providing FDA-compliant U.S.-collected plasma that can be used for medicines intended for the U.S. market. LFB Plasma operates a small multi-state center network and emphasizes donor safety, quality standards, and repeat donation programs. As part of LFB Group, it contributes to a broader plasma-derived therapeutics business spanning immunology, haemostasis, and intensive care.